187 related articles for article (PubMed ID: 23676762)
1. Physiologically-relevant modes of membrane interactions by the human antimicrobial peptide, LL-37, revealed by SFG experiments.
Ding B; Soblosky L; Nguyen K; Geng J; Yu X; Ramamoorthy A; Chen Z
Sci Rep; 2013; 3():1854. PubMed ID: 23676762
[TBL] [Abstract][Full Text] [Related]
2. Molecular Dynamics Simulations of Human Antimicrobial Peptide LL-37 in Model POPC and POPG Lipid Bilayers.
Zhao L; Cao Z; Bian Y; Hu G; Wang J; Zhou Y
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652823
[TBL] [Abstract][Full Text] [Related]
3. Conformation and Orientation of Antimicrobial Peptides MSI-594 and MSI-594A in a Lipid Membrane.
Yang P; Guo W; Ramamoorthy A; Chen Z
Langmuir; 2023 Apr; 39(15):5352-5363. PubMed ID: 37017985
[TBL] [Abstract][Full Text] [Related]
4. Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37.
Henzler-Wildman KA; Martinez GV; Brown MF; Ramamoorthy A
Biochemistry; 2004 Jul; 43(26):8459-69. PubMed ID: 15222757
[TBL] [Abstract][Full Text] [Related]
5. Membrane interaction of antimicrobial peptides using E. coli lipid extract as model bacterial cell membranes and SFG spectroscopy.
Soblosky L; Ramamoorthy A; Chen Z
Chem Phys Lipids; 2015 Apr; 187():20-33. PubMed ID: 25707312
[TBL] [Abstract][Full Text] [Related]
6. Membrane orientation of MSI-78 measured by sum frequency generation vibrational spectroscopy.
Yang P; Ramamoorthy A; Chen Z
Langmuir; 2011 Jun; 27(12):7760-7. PubMed ID: 21595453
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37.
Thennarasu S; Tan A; Penumatchu R; Shelburne CE; Heyl DL; Ramamoorthy A
Biophys J; 2010 Jan; 98(2):248-57. PubMed ID: 20338846
[TBL] [Abstract][Full Text] [Related]
8. SFG studies on interactions between antimicrobial peptides and supported lipid bilayers.
Chen X; Chen Z
Biochim Biophys Acta; 2006 Sep; 1758(9):1257-73. PubMed ID: 16524559
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
Henzler Wildman KA; Lee DK; Ramamoorthy A
Biochemistry; 2003 Jun; 42(21):6545-58. PubMed ID: 12767238
[TBL] [Abstract][Full Text] [Related]
10. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
Wang G; Mishra B; Epand RF; Epand RM
Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
[TBL] [Abstract][Full Text] [Related]
11. Lipid tails modulate antimicrobial peptide membrane incorporation and activity.
Walker LR; Marty MT
Biochim Biophys Acta Biomembr; 2022 Apr; 1864(4):183870. PubMed ID: 35077676
[TBL] [Abstract][Full Text] [Related]
12. The C-Terminal VPRTES Tail of LL-37 Influences the Mode of Attachment to a Lipid Bilayer and Antimicrobial Activity.
de Miguel Catalina A; Forbrig E; Kozuch J; Nehls C; Paulowski L; Gutsmann T; Hildebrandt P; Mroginski MA
Biochemistry; 2019 May; 58(19):2447-2462. PubMed ID: 31016971
[TBL] [Abstract][Full Text] [Related]
13. Interaction of LL-37 human cathelicidin peptide with a model microbial-like lipid membrane.
Majewska M; Zamlynny V; Pieta IS; Nowakowski R; Pieta P
Bioelectrochemistry; 2021 Oct; 141():107842. PubMed ID: 34049238
[TBL] [Abstract][Full Text] [Related]
14. Identifying the selectivity of antimicrobial peptides to cell membranes by sum frequency generation spectroscopy.
Golbek TW; Franz J; Elliott Fowler J; Schilke KF; Weidner T; Baio JE
Biointerphases; 2017 May; 12(2):02D406. PubMed ID: 28476090
[TBL] [Abstract][Full Text] [Related]
15. Membrane Core-Specific Antimicrobial Action of Cathelicidin LL-37 Peptide Switches Between Pore and Nanofibre Formation.
Shahmiri M; Enciso M; Adda CG; Smith BJ; Perugini MA; Mechler A
Sci Rep; 2016 Nov; 6():38184. PubMed ID: 27901075
[TBL] [Abstract][Full Text] [Related]
16. Solid-state nuclear magnetic resonance relaxation studies of the interaction mechanism of antimicrobial peptides with phospholipid bilayer membranes.
Lu JX; Damodaran K; Blazyk J; Lorigan GA
Biochemistry; 2005 Aug; 44(30):10208-17. PubMed ID: 16042398
[TBL] [Abstract][Full Text] [Related]
17. Probing Site-Specific Structural Information of Peptides at Model Membrane Interface In Situ.
Ding B; Panahi A; Ho JJ; Laaser JE; Brooks CL; Zanni MT; Chen Z
J Am Chem Soc; 2015 Aug; 137(32):10190-8. PubMed ID: 26241117
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol, lanosterol, and ergosterol attenuate the membrane association of LL-37(W27F) and temporin L.
Sood R; Kinnunen PK
Biochim Biophys Acta; 2008 Jun; 1778(6):1460-6. PubMed ID: 18358828
[TBL] [Abstract][Full Text] [Related]
19. Elementary Processes and Mechanisms of Interactions of Antimicrobial Peptides with Membranes-Single Giant Unilamellar Vesicle Studies.
Hasan M; Yamazaki M
Adv Exp Med Biol; 2019; 1117():17-32. PubMed ID: 30980351
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical-guided design of cathelicidin-derived peptides generates membrane active variants with therapeutic potential.
Oliveira NGJ; Cardoso MH; Velikova N; Giesbers M; Wells JM; Rezende TMB; de Vries R; Franco OL
Sci Rep; 2020 Jun; 10(1):9127. PubMed ID: 32499582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
